Clinical Trials Directory

Trials / Completed

CompletedNCT03469180

Comparison of Treadmill and Whole Body Vibration Training in Children With Attention Deficit Hyperactivity Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Bezmialem Vakif University · Academic / Other
Sex
All
Age
7 Years – 11 Years
Healthy volunteers
Not accepted

Summary

It is reported in the literature that children with attention deficit hyperactivity disorder (ADHD) may have executive function deficits, impaired social functions, emotional dysregulation, behavioral disorders and motor impairments. Furthermore, studies have shown that exercise, such as acute and chronic aerobic exercises and acute whole body vibration training, improves executive functions and motor abilities and so it is hypothesized that exercise may have a potential or additional treatment option for children with ADHD. Neurobiological researches have already proven the effects on brain changes during exercise and in the case of ADHD, increasing levels of serotonin, dopamine, and norepinephrine within the front striatal lobes of the brain were highlighted when discussing the effects on this neurodevelopmental disorder. The literature emphasizes the importance of physical activity in children with ADHD, but there is no clarity regarding the frequency, intensity or duration of the exercise. Thus, the aim of this study was to investigate and compare the effects of treadmill training as an aerobic exercise and whole body vibration training on executive functions and balance in children with ADHD.

Conditions

Interventions

TypeNameDescription
OTHERTreadmill trainingTreadmill training Each season will be supervised and last 45 minutes. Treadmill speed will be adjusted to the child's maximal heart rate (MHR) (between 65 to 75 percent of the MHR).
OTHERWhole body vibration trainingWhole body vibration training whole body vibration frequence will be 50 Hertz and childrens will be standing position on vibration platform .

Timeline

Start date
2018-03-24
Primary completion
2018-06-01
Completion
2018-06-30
First posted
2018-03-19
Last updated
2018-07-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03469180. Inclusion in this directory is not an endorsement.